https://www.selleckchem.com/products/OSI027.html
Lastly, rescue assays affirmed the tumor-restraining role of miR-596-BRD4/KPNA4 axis in EOC. EP300-activated miR-596 hampered cell growth and stemness via targeting BRD4 and KPNA4 in EOC, proofing miR-596 as a promising therapeutic target in treating EOC patients. EP300-activated miR-596 hampered cell growth and stemness via targeting BRD4 and KPNA4 in EOC, proofing miR-596 as a promising therapeutic target in treating EOC patients. To analyze the clinical efficacy of intraoperative radiotherapy (IORT) after breast-conserving surgery (BC
Gefällt mir
Kommentar
Teilen
